Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mid-axillary ultrasound-guided TAP block vs local wound infiltration for postoperative analgesia in laparoscopic radical prostatectomy
2019-004089-16Phase 4Completed
- Sponsor
- Consorci Sanitari Integral
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in prostate cancer (PCa) (2 arms), sponsored by Consorci Sanitari Integral. Primary endpoint: Assessment of acute postoperative pain. Started May 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2019-004089-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004089-16.